Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C13H18N2O4S2 |
| Molecular Weight | 330.423 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1(C)S[C@@H]2[C@H](NC(=O)CSCC=C)C(=O)N2[C@H]1C(O)=O
InChI
InChIKey=QULKGELYPOJSLP-WCABBAIRSA-N
InChI=1S/C13H18N2O4S2/c1-4-5-20-6-7(16)14-8-10(17)15-9(12(18)19)13(2,3)21-11(8)15/h4,8-9,11H,1,5-6H2,2-3H3,(H,14,16)(H,18,19)/t8-,9+,11-/m1/s1
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
1000000 unit 1 times / day multiple, intramuscular Highest studied dose Dose: 1000000 unit, 1 times / day Route: intramuscular Route: multiple Dose: 1000000 unit, 1 times / day Sources: |
unhealthy, 23 years |
Other AEs: Nausea, Increased salivation... |
600000 unit single, intramuscular Dose: 600000 unit Route: intramuscular Route: single Dose: 600000 unit Sources: |
unhealthy, 23 years |
Disc. AE: Anaphylactic shock... AEs leading to discontinuation/dose reduction: Anaphylactic shock (severe) Sources: |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Increased salivation | 1000000 unit 1 times / day multiple, intramuscular Highest studied dose Dose: 1000000 unit, 1 times / day Route: intramuscular Route: multiple Dose: 1000000 unit, 1 times / day Sources: |
unhealthy, 23 years |
|
| Nausea | mild | 1000000 unit 1 times / day multiple, intramuscular Highest studied dose Dose: 1000000 unit, 1 times / day Route: intramuscular Route: multiple Dose: 1000000 unit, 1 times / day Sources: |
unhealthy, 23 years |
| Anaphylactic shock | severe Disc. AE |
600000 unit single, intramuscular Dose: 600000 unit Route: intramuscular Route: single Dose: 600000 unit Sources: |
unhealthy, 23 years |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Studies on the mechanism of the formation of the penicillin antigen. I. Delayed allergic cross-reactions among penicillin G and its degradation products. | 1960-12-01 |
|
| Some immunochemical properties of penicillenic acid. An antigenic determinant derived from penicillin. | 1960-12-01 |
|
| Clinical and pharmacologic studies with allylmercaptomethyl penicillin (penicillin O). | 1951-08 |
|
| Use of penicillin O in patients hypersensitive to pencilling G. | 1950-07-01 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1500
Created by
admin on Mon Mar 31 18:07:36 GMT 2025 , Edited by admin on Mon Mar 31 18:07:36 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1575
Created by
admin on Mon Mar 31 18:07:36 GMT 2025 , Edited by admin on Mon Mar 31 18:07:36 GMT 2025
|
PRIMARY | |||
|
m8478
Created by
admin on Mon Mar 31 18:07:36 GMT 2025 , Edited by admin on Mon Mar 31 18:07:36 GMT 2025
|
PRIMARY | Merck Index | ||
|
C80247
Created by
admin on Mon Mar 31 18:07:36 GMT 2025 , Edited by admin on Mon Mar 31 18:07:36 GMT 2025
|
PRIMARY | |||
|
51207
Created by
admin on Mon Mar 31 18:07:36 GMT 2025 , Edited by admin on Mon Mar 31 18:07:36 GMT 2025
|
PRIMARY | |||
|
DTXSID50236034
Created by
admin on Mon Mar 31 18:07:36 GMT 2025 , Edited by admin on Mon Mar 31 18:07:36 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105909
Created by
admin on Mon Mar 31 18:07:36 GMT 2025 , Edited by admin on Mon Mar 31 18:07:36 GMT 2025
|
PRIMARY | |||
|
71365
Created by
admin on Mon Mar 31 18:07:36 GMT 2025 , Edited by admin on Mon Mar 31 18:07:36 GMT 2025
|
PRIMARY | |||
|
87-09-2
Created by
admin on Mon Mar 31 18:07:36 GMT 2025 , Edited by admin on Mon Mar 31 18:07:36 GMT 2025
|
PRIMARY | |||
|
6246WH0S1O
Created by
admin on Mon Mar 31 18:07:36 GMT 2025 , Edited by admin on Mon Mar 31 18:07:36 GMT 2025
|
PRIMARY | |||
|
100000087440
Created by
admin on Mon Mar 31 18:07:36 GMT 2025 , Edited by admin on Mon Mar 31 18:07:36 GMT 2025
|
PRIMARY | |||
|
3422
Created by
admin on Mon Mar 31 18:07:36 GMT 2025 , Edited by admin on Mon Mar 31 18:07:36 GMT 2025
|
PRIMARY | |||
|
Almecillin
Created by
admin on Mon Mar 31 18:07:36 GMT 2025 , Edited by admin on Mon Mar 31 18:07:36 GMT 2025
|
PRIMARY | |||
|
SUB05345MIG
Created by
admin on Mon Mar 31 18:07:36 GMT 2025 , Edited by admin on Mon Mar 31 18:07:36 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)